EYP

EyePoint, Inc.

Stock
Stock
Ticker: EYPT
EYPT

Price

Price

CHART BY

Frequently asked questions

The market capitalization of EyePoint, Inc. is $30.74M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
EyePoint, Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.964. EPS indicates the company's profitability on a per-share basis.
Currently, 13 analysts cover EyePoint, Inc.'s stock, with a consensus target price of $12.28. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, EyePoint, Inc. reported a revenue of $2.58M.
EyePoint, Inc. employs approximately 214 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of EyePoint, Inc. is 80.71M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$30.74M
EPS (TTM) 
-$3.964
Free Float 
80.71M
Revenue (TTM) 
$2.58M

Pricing

1D span
$0.319$0.336
52W span
$0.31$19.00

Analyst Ratings

The price target is $12.28 and the stock is covered by 13 analysts.

Buy

4

Hold

8

Sell

1

Information

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Employees
214
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
EYPT

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin